| Name: | Budesonide Sulfate Sodium Impurity |
| Catalogue No. | VE007475 |
| CAS No. | N/A |
| Molecular Formula | C25H33O9S |
| Molecular Weight | 509.60 g/mol |
| Status | In-Stock |
| IUPAC Name | sodium 2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-6a,8a-dimethyl-4-oxo-10-propyl-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl sulfate |
| Description | Budesonide Sulfate Sodium Impurity(CAS No: N/A ) or sodium 2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-6a,8a-dimethyl-4-oxo-10-propyl-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl sulfate is associate impurity of Budesonide. is a corticosteroid that used to treat Crohn's disease and it also treat respiratory and digestive conditions,Airways Disease. |
| References | Benefit:Risk Profile of Budesonide in Obstructive Airways Disease By Donald P. Tashkin, Brian Lipworth, Ralph Brattsand Container: Drugs Year: 2019 Volume: 79 Issue: 16 DOI: 10.1007/s40265-019-01198-7 URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825643/ IN-TEXT CITATION |
